{"nct_id":"NCT06305767","title":"A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2024-03-28","start_date_type":"ACTUAL","primary_completion_date":"2027-04-23","primary_completion_date_type":"ESTIMATED","completion_date":"2031-10-20","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["MRK"]}